DK1542904T3 - Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser - Google Patents

Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser

Info

Publication number
DK1542904T3
DK1542904T3 DK03791745T DK03791745T DK1542904T3 DK 1542904 T3 DK1542904 T3 DK 1542904T3 DK 03791745 T DK03791745 T DK 03791745T DK 03791745 T DK03791745 T DK 03791745T DK 1542904 T3 DK1542904 T3 DK 1542904T3
Authority
DK
Denmark
Prior art keywords
metered dose
dose inhaler
container
suspension
solution
Prior art date
Application number
DK03791745T
Other languages
Danish (da)
English (en)
Inventor
Saeed Chaudhry
Stefan A Sharpe
Julianne Berry
Joel A Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1542904T3 publication Critical patent/DK1542904T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/003—Adding propellants in fluid form to aerosol containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK03791745T 2002-08-27 2003-08-26 Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser DK1542904T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40612702P 2002-08-27 2002-08-27
US42243602P 2002-10-30 2002-10-30
PCT/US2003/026512 WO2004020289A1 (en) 2002-08-27 2003-08-26 Process for producing metered dose inhaler formulations

Publications (1)

Publication Number Publication Date
DK1542904T3 true DK1542904T3 (da) 2008-04-21

Family

ID=31981380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03791745T DK1542904T3 (da) 2002-08-27 2003-08-26 Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser

Country Status (14)

Country Link
US (3) US20040042973A1 (es)
EP (2) EP1878664B1 (es)
JP (3) JP4679901B2 (es)
AT (2) ATE503687T1 (es)
AU (1) AU2003265639A1 (es)
CA (1) CA2495875C (es)
CY (1) CY1107376T1 (es)
DE (2) DE60318727T2 (es)
DK (1) DK1542904T3 (es)
ES (1) ES2297262T3 (es)
MX (1) MXPA05002248A (es)
PT (1) PT1542904E (es)
SI (1) SI1542904T1 (es)
WO (1) WO2004020289A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
MXPA05002060A (es) * 2002-08-23 2005-06-08 Schering Corp Composiciones farmaceuticas.
US20050136009A1 (en) * 2003-10-20 2005-06-23 Schering Corporation Pharmaceutical compositions
SE0401408D0 (sv) * 2004-06-02 2004-06-02 Astrazeneca Ab Diameter measuring device
ES2317306T3 (es) * 2004-10-12 2009-04-16 Generics (Uk) Limited Procedimiento para la preparacion de formulaciones en aerosol en suspension, en el que las particulas se forman por precipitacion dentro de un frasco de aerosol.
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2008047149A1 (en) * 2006-10-19 2008-04-24 Cipla Limited Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
EP2117504A1 (en) 2007-02-09 2009-11-18 Schering Corporation Stable pharmaceutical drug aerosols
CN102458382B (zh) 2009-05-12 2015-03-18 咖勒尼卡公司 莫米松和丙二醇的水包油乳状液
EP2429490B1 (en) * 2009-05-12 2016-11-23 Galenica AB Oil-in-water emulsion of mometasone
AU2015200276B2 (en) * 2010-02-10 2016-01-21 Astrazeneca Uk Limited A filled canister for an inhaler
NZ601454A (en) * 2010-02-10 2014-06-27 Astrazeneca Uk Ltd Process for providing a filled canister for an inhaler
CN107626019A (zh) * 2016-07-18 2018-01-26 卓效医疗有限公司 手持式喷雾器
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592319A (en) * 1968-10-28 1971-07-13 Roy S Rousseau Article feed control
US3835898A (en) * 1972-11-13 1974-09-17 Kartridg Pak Co Remotely adjustable filling head
US4793461A (en) * 1987-02-26 1988-12-27 The Kartridg Pak Co. Container feed apparatus
US5143260A (en) * 1990-06-05 1992-09-01 Nozone Dispenser Systems, Inc. Aerosol adapter clamp and power system
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
JPH06508149A (ja) * 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
US5275212A (en) * 1993-02-24 1994-01-04 Minnesota Mining And Manufacturing Company Aerosol filling method
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US5698161A (en) 1996-08-26 1997-12-16 Michigan Critical Care Consultants, Inc. Hollow, multi-dimensional array membrane
JP3264496B2 (ja) * 1996-08-29 2002-03-11 シェーリング コーポレイション クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
AU2001278115A1 (en) 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
MXPA05002060A (es) * 2002-08-23 2005-06-08 Schering Corp Composiciones farmaceuticas.
US20050136009A1 (en) * 2003-10-20 2005-06-23 Schering Corporation Pharmaceutical compositions
US20070203104A1 (en) * 2006-02-09 2007-08-30 Chaudhry Saeed M Pharmaceutical Formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Also Published As

Publication number Publication date
SI1542904T1 (sl) 2008-06-30
CA2495875C (en) 2010-06-22
JP2011046726A (ja) 2011-03-10
CA2495875A1 (en) 2004-03-11
ATE503687T1 (de) 2011-04-15
JP2006305390A (ja) 2006-11-09
JP2005537095A (ja) 2005-12-08
DE60336602D1 (de) 2011-05-12
ES2297262T3 (es) 2008-05-01
US20130068218A1 (en) 2013-03-21
DE60318727D1 (de) 2008-03-06
EP1542904B1 (en) 2008-01-16
CY1107376T1 (el) 2012-12-19
WO2004020289A1 (en) 2004-03-11
EP1878664B1 (en) 2011-03-30
JP4679901B2 (ja) 2011-05-11
US20040042973A1 (en) 2004-03-04
MXPA05002248A (es) 2005-06-08
ATE384001T1 (de) 2008-02-15
EP1878664A1 (en) 2008-01-16
EP1542904A1 (en) 2005-06-22
PT1542904E (pt) 2008-03-24
DE60318727T2 (de) 2009-01-08
US20080066744A1 (en) 2008-03-20
AU2003265639A1 (en) 2004-03-19

Similar Documents

Publication Publication Date Title
CY1107376T1 (el) Μεθοδος παρασκευης συνταγοποιησεων για συσκευη εισπνοης μετρημενης δοσης
FI2515855T6 (fi) Yhdistelmähoito keuhkoahtaumatautia (copd) varten
UA89751C2 (ru) Состав, который содержит сульфат альбутерола и бромид ипратропия, способ его получения и ингалятор
NZ737862A (en) High-concentration monoclonal antibody formulations
CA2353959A1 (en) A medicinal aerosol formulation
SE0402976L (sv) Medicinsk produkt
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
MX335944B (es) Composiciones que comprenden sulfato de salbutamol.
WO2009124257A3 (en) Radiolabeled treatment infusion system, apparatus, and methods of using the same
JP2014530231A5 (es)
MX2021006751A (es) Inhalador de polvo seco con propionato de fluticasona y xinafoato de salmeterol.
AR039317A1 (es) Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion
MX2015014513A (es) Composicion que comprende sulfato de salbutamol.
NZ599900A (en) Pharmaceutical suspension aerosol formulations for use in metered dose inhalers
PH12021550767A1 (en) Pharmaceutical compositions comprising rpl554 in hfa-134a for administration by inhalation
ATE293957T1 (de) Verfahren zur herstellung von inhalationspulvern
MX2023003754A (es) Formulacion farmaceutica para inhalador presurizado de dosis medidas.
WO2015169974A8 (en) Aerosol device
US20110240504A1 (en) Method and apparatus for packaging and dispensing pharmaceuticals
MX2019000651A (es) Metodo y sistema para suministro de medicamento en aerosol.
BRPI0607990A2 (pt) formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
MX2007003468A (es) Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.
JP6018438B2 (ja) 滴下式エアゾール製品